What can be added to Augmentin (amoxicillin/clavulanate) for more coverage?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 6, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Antibiotic Options to Add to Augmentin for Enhanced Coverage

When additional coverage beyond Augmentin (amoxicillin/clavulanate) is needed, the most appropriate agent to add depends on the specific clinical scenario, with macrolides being the most commonly recommended addition for respiratory infections.

Understanding Augmentin's Coverage

  • Augmentin provides broad-spectrum coverage against many common pathogens including Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis, and beta-lactamase producing organisms 1
  • It is effective against many respiratory, skin, and urinary tract infections as a standalone agent 2
  • Despite its broad coverage, certain pathogens may require additional antimicrobial agents 3

When to Add Additional Coverage to Augmentin

For Community-Acquired Pneumonia:

  • For outpatients with cardiopulmonary disease or other modifying factors, add a macrolide (azithromycin or clarithromycin) or doxycycline to Augmentin to cover atypical pathogens 3
  • This combination provides coverage for both typical pathogens (via Augmentin) and atypical pathogens like Mycoplasma pneumoniae and Chlamydia pneumoniae (via macrolide/doxycycline) 3
  • For hospitalized patients with CAP, a beta-lactam (like Augmentin) plus a macrolide is recommended to ensure adequate coverage 3

For COPD Exacerbations:

  • In patients with severe COPD exacerbations (Group C patients), particularly those with risk factors for Pseudomonas aeruginosa or antibiotic resistance, consider adding agents with pseudomonal coverage 3
  • For Group B COPD patients, respiratory fluoroquinolones (levofloxacin, moxifloxacin) can be considered as alternatives to Augmentin or added for broader coverage 3

For Acute Bacterial Rhinosinusitis:

  • For patients with mild disease who fail initial therapy with Augmentin, consider adding or switching to a respiratory fluoroquinolone (gatifloxacin, levofloxacin, moxifloxacin) 3
  • For moderate disease or recent antibiotic use, combination therapy with adequate gram-positive and gram-negative coverage may be appropriate 3

Specific Agents to Consider Adding

For Atypical Pathogen Coverage:

  • Macrolides: Azithromycin or clarithromycin are preferred over erythromycin due to better tolerability and coverage of H. influenzae 3
  • Doxycycline: An alternative to macrolides, particularly useful in patients with macrolide allergies 3

For Resistant Pathogens:

  • Respiratory fluoroquinolones: Levofloxacin, moxifloxacin provide excellent coverage against resistant S. pneumoniae and H. influenzae 3
  • Ceftriaxone: For parenteral therapy when oral agents are insufficient 3

For Anaerobic Coverage:

  • Metronidazole: Can be added when anaerobic coverage is needed, particularly in aspiration pneumonia 3
  • Clindamycin: Alternative for anaerobic coverage, particularly useful in lung abscess 3

Important Caveats and Considerations

  • Avoid combining Augmentin with cefixime or other similar cephalosporins as this provides redundant coverage without additional benefit 4
  • Consider local resistance patterns when selecting additional agents 3
  • For patients with penicillin allergies, alternative regimens should be considered rather than adding to Augmentin 3
  • When switching therapy due to treatment failure, consider the limitations in coverage of the initial agent 3

Dosing Considerations

  • Augmentin can be dosed twice daily (875/125 mg) with similar efficacy to three-times-daily dosing, which may improve compliance when combined with other antibiotics 5
  • For severe infections, high-dose Augmentin formulations (2000/125 mg twice daily for adults) may be more appropriate than adding another agent 1

Remember that antibiotic selection should always consider local resistance patterns, patient-specific factors, and the suspected pathogens based on the clinical presentation.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.